Effect of Bilateral Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) on drug reduction for Parkinson’s Disease: A retrospective observational study from Pakistan
2024

Deep Brain Stimulation for Parkinson's Disease

Sample size: 49 publication Evidence: high

Author Information

Author(s): Khan Zubair Mustafsa, Ahmad Shahzeb, Qadri Haseeb Mehmood, Khizar Ahtesham, Bashir Asif

Primary Institution: Punjab Institute of Neurosciences, Lahore, Pakistan

Hypothesis

Bilateral Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) can reduce the need for medication in Parkinson's disease patients.

Conclusion

Bilateral STN DBS is an effective treatment for early-stage Parkinson's disease, significantly reducing the need for levodopa and improving motor symptoms.

Supporting Evidence

  • LEDD reduced by 55.03% after DBS.
  • UPDRS-III improved by 80.49% post-surgery.
  • Time spent with dyskinesia decreased by 17.54%.
  • Time spent off medication increased by 22.44%.

Takeaway

Doctors used a special brain surgery to help people with Parkinson's disease take less medicine and feel better.

Methodology

This was a retrospective cohort study involving 49 patients who underwent bilateral STN DBS over five years.

Potential Biases

There may be risks of bias due to the non-probability sampling method.

Limitations

The study's weaknesses include its retrospective nature, limited sample size, and shorter follow-up duration.

Participant Demographics

The mean age of participants was 56.79 years, with 80% male and 20% female.

Statistical Information

P-Value

0.0001

Confidence Interval

95%

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.12669/pjms.40.12(PINS).11111

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication